NL-OMON52268招募中4 期
Corcym Mitral, Aortic aNd Tricuspid post-maRket Study in a reAl-world setting - MANTRA study LNH800
Corcym S.r.l0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Signed and dated approved Informed Consent
- •- Subject is willing and able to comply with the follow up schedule of the
- •- Eligible for treatment with Corcym aortic, mitral/tricuspid products as
- •outlined in the applicable IFUs
排除标准
- •-Subject is already participating to another clinical investigation that could
- •confound the results of this clinical investigation
- •-Subject has a life expectancy <= 12 months
- •-Subject has contraindications to the use of Corcym aortic, mitral and/or
- •tricuspid devices as outlined in the applicable Instructions For Use (IFU)
研究者
相似试验
Unknown
不适用
moderate ischemic mitral regurgeCardiologyCirculatory Systemmitral valve diseasePACTR201710002640828menoufia university40
已完成
不适用
Comparison of clinical outcomes following mitral valve repair and replacement in ischemic mitral valve regurgitation.ischemic mitral valve regurgitationIschemic mitral valve regurgitation,Mitral valve replacement,Mitral valve repair,Coronary artery bypass graftTCTR20191102001Cardiothoracic surgery research group53
撤回
4 期
Transcatheter Repair of Mitral Regurgitation with Cardioband System Post Market Study (MiBAND): A European prospective, multicenter study to assess transcatheter mitral valve repair with Edwards Cardioband System in patients with symptomatic mitral regurgitation.mitral insufficiencyNL-OMON49230Edwards Lifesciences, LCC5
尚未招募
不适用
ong-term follow-up after restrictive mitral annuloplasty for functional mitral regurgitation.Mitral regurgitation1004697310007593NL-OMON42573eids Universitair Medisch Centrum200
尚未招募
不适用
Follow up of IMT in post-coarctectomy patientscoarctationcongenital narrowed aorta10010394NL-OMON33815Academisch Medisch Centrum137